Caprock Group LLC Has $388,000 Stock Holdings in Chemed Co. (NYSE:CHE)

Caprock Group LLC trimmed its holdings in Chemed Co. (NYSE:CHE) by 15.8% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 646 shares of the company’s stock after selling 121 shares during the quarter. Caprock Group LLC’s holdings in Chemed were worth $388,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CHE. GAMMA Investing LLC raised its stake in shares of Chemed by 34.4% in the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after acquiring an additional 22 shares during the last quarter. American National Bank & Trust bought a new position in Chemed in the 3rd quarter worth approximately $61,000. Mather Group LLC. lifted its holdings in Chemed by 60.5% during the 2nd quarter. Mather Group LLC. now owns 183 shares of the company’s stock worth $99,000 after buying an additional 69 shares in the last quarter. Quarry LP boosted its position in Chemed by 721.7% in the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after buying an additional 166 shares during the last quarter. Finally, LRI Investments LLC acquired a new stake in shares of Chemed in the 1st quarter valued at $171,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CHE. Royal Bank of Canada cut their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th. StockNews.com downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research report on Friday.

Chemed Stock Up 1.4 %

Shares of Chemed stock opened at $570.96 on Friday. The business has a fifty day simple moving average of $579.08 and a 200 day simple moving average of $565.16. The stock has a market cap of $8.59 billion, a PE ratio of 28.85, a price-to-earnings-growth ratio of 2.39 and a beta of 0.46. Chemed Co. has a 12 month low of $523.33 and a 12 month high of $654.62.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). The company had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. Chemed’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.32 earnings per share. Analysts expect that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Monday, November 18th will be given a dividend of $0.50 per share. The ex-dividend date is Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. Chemed’s dividend payout ratio is 10.11%.

Insider Activity

In other news, Director George J. Walsh III sold 400 shares of the stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the sale, the director now owns 3,046 shares of the company’s stock, valued at $1,819,893.62. This represents a 11.61 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the business’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $569.35, for a total value of $975,296.55. Following the completion of the sale, the executive vice president now owns 6,109 shares in the company, valued at approximately $3,478,159.15. This trade represents a 21.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,113 shares of company stock valued at $2,411,905 in the last quarter. Company insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.